MedCap AB (OSTO:MCAP) Other Operating Expense: kr993 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MCAP MedCap AB OSTO:MCAP
83 GF Score
Price kr556.50
GF Value kr566.58
Valuation Fairly Valued
View Full Analysis

What is MedCap AB Other Operating Expense?

MedCap AB OSTO:MCAP +1.37% 83 Other Operating Expense is kr993 Mil as of Jun. 2026. GuruFocus rates OSTO:MCAP with a GF Score™ of 83/100 and a GF Value™ of kr566.58 (Fairly Valued).

MedCap AB's Other Operating Expense for the three months ended in Jun. 2026 was kr261 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr993 Mil.

MedCap AB's quarterly Other Operating Expense declined from Dec. 2025 (kr262 Mil) to Mar. 2026 (kr255 Mil) but then increased from Mar. 2026 (kr255 Mil) to Jun. 2026 (kr261 Mil).

MedCap AB's annual Other Operating Expense increased from Dec. 2023 (kr711 Mil) to Dec. 2024 (kr816 Mil) and increased from Dec. 2024 (kr816 Mil) to Dec. 2025 (kr947 Mil).

MedCap AB Other Operating Expense Historical Data

* Premium members only.

The historical data trend for MedCap AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB Other Operating Expense Chart

MedCap AB Annual Data
Trend Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 460.70 527.90 711.30 816.20 947.30

MedCap AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 231.10 216.10 261.50 254.80 260.90
OSTO:MCAP
83GF Score
MedCap AB OSTO:MCAP
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedCap AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr993 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr993 Mil mean?
MedCap AB (OSTO:MCAP) has a Other Operating Expense of kr993 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on MedCap AB and its competitors.
Is MedCap AB's Other Operating Expense too high?
MedCap AB's current Other Operating Expense is kr993 Mil. Overall, MedCap AB has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Other Operating Expense compare to ABT and SYK?
MedCap AB's Other Operating Expense of kr993 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on MedCap AB and its competitors. MedCap AB's current Other Operating Expense is kr993 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr566.58, compared to a current price of kr556.50 — trading 1.8% below its estimated fair value. The current Other Operating Expense is kr993 Mil. MedCap AB's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current Other Operating Expense is kr993 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedCap AB (OSTO:MCAP) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of kr556.50 is trading 1.8% below its estimated GF Value™ of kr566.58. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for OSTO:MCAP:

  • Other Operating Expense: kr993 Mil
  • GF Value™: kr566.58 vs. price of kr556.50 (1.8% below fair value)
  • GF Score™: 83/100

No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MedCap AB Business Description

Other Exchanges MCAPs:UK61MA:Germany
Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
83GF Score

Get the complete analysis for OSTO:MCAP

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr556.50
Price
kr566.58
GF Value